-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-19
Values as of: 2025-04-19
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is in Phase 2 clinical studies for the treatment of solid tumor, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, colon cancer and glioblastoma multiforme, in combination with a range of anti-cancer regimens. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Company Website : https://www.lisata.com
Currency: USD
Country : UK
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
0R2F:LSE | Wells Fargo & Company |
N/A |
USD 9,223,372,036.85B |
0R2T:LSE | Micron Technology Inc |
N/A |
USD 9,223,372,036.85B |
0R15:LSE | SoftBank Group Corp. |
N/A |
USD 9,217.80B |
0R1E:LSE | Nintendo Co. Ltd. |
N/A |
USD 7,596.04B |
0M69:LSE | OTP Bank Nyrt |
N/A |
USD 5,014.80B |
0R28:LSE | Newmont Corp. |
N/A |
USD 4,231.43B |
0R2O:LSE | Freeport-McMoRan Inc. |
N/A |
USD 4,154.37B |
0QYD:LSE | Yum! Brands Inc. |
N/A |
USD 4,109.92B |
0Y4Q:LSE | Willis Towers Watson PLC |
N/A |
USD 4,090.61B |
0LD9:LSE | Targa Resources Corp. |
N/A |
USD 4,072.69B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
EATZ | AdvisorShares Restaurant .. | 6.30 % | 0.00 % |
N/A |
USD 3.90M |
HAU-U:CA | 3.45 % | 0.00 % |
N/A |
N/A | |
PEJ | Invesco Dynamic Leisure a.. | 3.28 % | 0.63 % |
N/A |
N/A |
RCD | Ready Capital Corporation.. | 2.16 % | 0.40 % |
N/A |
N/A |
FXD | First Trust Consumer Disc.. | 1.42 % | 0.64 % |
N/A |
USD 0.40B |
IUSF:LSE | iShares IV Public Limited.. | 0.42 % | 0.00 % |
N/A |
USD 0.31B |
IUSZ:LSE | iShares Edge MSCI USA Siz.. | 0.42 % | 0.00 % |
N/A |
USD 0.31B |
QDVC:F | iShares IV Public Limited.. | 0.41 % | 0.00 % |
N/A |
N/A |
QDVC:XETRA | iShares Edge MSCI USA Siz.. | 0.41 % | 0.00 % |
N/A |
N/A |
RXI | iShares Global Consumer D.. | 0.00 % | 0.46 % |
N/A |
N/A |
XDEW:LSE | Xtrackers S&P 500 Equal W.. | 0.00 % | 0.00 % |
N/A |
N/A |
XDWE:LSE | Xtrackers (IE) Public Lim.. | 0.00 % | 0.00 % |
N/A |
N/A |
XDEW:XETRA | Xtrackers S&P 500 Equal W.. | 0.00 % | 0.00 % |
N/A |
N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike